BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28738904)

  • 1. Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.
    Lalive PH; Kreutzfeldt M; Devergne O; Metz I; Bruck W; Merkler D; Pot C
    J Neuroinflammation; 2017 Jul; 14(1):144. PubMed ID: 28738904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
    Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
    J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.
    Maimone D; Gregory S; Arnason BG; Reder AT
    J Neuroimmunol; 1991 Apr; 32(1):67-74. PubMed ID: 2002092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis.
    Bradford CM; Ramos I; Cross AK; Haddock G; McQuaid S; Nicholas AP; Woodroofe MN
    J Neuroimmunol; 2014 Aug; 273(1-2):85-95. PubMed ID: 24907905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients.
    Crick PJ; Griffiths WJ; Zhang J; Beibel M; Abdel-Khalik J; Kuhle J; Sailer AW; Wang Y
    Mol Neurobiol; 2017 Dec; 54(10):8009-8020. PubMed ID: 27878760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.
    Matsui M; Araya S; Wang HY; Matsushima K; Saida T
    J Neurol; 2005 Aug; 252(8):908-15. PubMed ID: 15772738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
    Perriard G; Mathias A; Enz L; Canales M; Schluep M; Gentner M; Schaeren-Wiemers N; Du Pasquier RA
    J Neuroinflammation; 2015 Jun; 12():119. PubMed ID: 26077779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
    Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet disease.
    Belghith M; Bahrini K; Kchaou M; Maghrebi O; Belal S; Barbouche MR
    Cytokine; 2018 Aug; 108():160-167. PubMed ID: 29625335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
    Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.
    Ghezzi L; Cantoni C; Cignarella F; Bollman B; Cross AH; Salter A; Galimberti D; Cella M; Piccio L
    Mult Scler; 2020 Sep; 26(10):1172-1186. PubMed ID: 31237799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
    Hulshof S; Montagne L; De Groot CJ; Van Der Valk P
    Glia; 2002 Apr; 38(1):24-35. PubMed ID: 11921201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases.
    Wullschleger A; Kapina V; Molnarfi N; Courvoisier DS; Seebach JD; Santiago-Raber ML; Hochstrasser DF; Lalive PH
    PLoS One; 2013; 8(8):e72399. PubMed ID: 24015240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.